TAK
Price
$14.68
Change
-$0.16 (-1.08%)
Updated
Jul 11 closing price
Capitalization
43.11B
18 days until earnings call
ZTS
Price
$154.96
Change
-$3.84 (-2.42%)
Updated
Jul 11 closing price
Capitalization
77.48B
24 days until earnings call
Interact to see
Advertisement

TAK vs ZTS

Header iconTAK vs ZTS Comparison
Open Charts TAK vs ZTSBanner chart's image
Takeda Pharmaceutical
Price$14.68
Change-$0.16 (-1.08%)
Volume$3.17M
Capitalization43.11B
ZOETIS
Price$154.96
Change-$3.84 (-2.42%)
Volume$2.27M
Capitalization77.48B
TAK vs ZTS Comparison Chart in %
Loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TAK vs. ZTS commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TAK is a StrongBuy and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (TAK: $14.68 vs. ZTS: $154.96)
Brand notoriety: TAK: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TAK: 141% vs. ZTS: 75%
Market capitalization -- TAK: $43.11B vs. ZTS: $77.48B
TAK [@Pharmaceuticals: Other] is valued at $43.11B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TAK’s FA Score shows that 2 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • TAK’s FA Score: 2 green, 3 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, TAK is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TAK’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 2 bullish TA indicator(s).

  • TAK’s TA Score: 4 bullish, 5 bearish.
  • ZTS’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, TAK is a better buy in the short-term than ZTS.

Price Growth

TAK (@Pharmaceuticals: Other) experienced а -4.30% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -2.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +53.35%. For the same industry, the average monthly price growth was +4.99%, and the average quarterly price growth was +71.83%.

Reported Earning Dates

TAK is expected to report earnings on Oct 30, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+53.35% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than TAK($43.1B). TAK has higher P/E ratio than ZTS: TAK (36.79) vs ZTS (32.94). TAK YTD gains are higher at: 10.876 vs. ZTS (-4.282). TAK has higher annual earnings (EBITDA): 1.01T vs. ZTS (3.67B). TAK has more cash in the bank: 317B vs. ZTS (2.04B). ZTS has less debt than TAK: ZTS (6.76B) vs TAK (4.66T). TAK has higher revenues than ZTS: TAK (4.17T) vs ZTS (8.54B).
TAKZTSTAK / ZTS
Capitalization43.1B77.5B56%
EBITDA1.01T3.67B27,660%
Gain YTD10.876-4.282-254%
P/E Ratio36.7932.94112%
Revenue4.17T8.54B48,794%
Total Cash317B2.04B15,547%
Total Debt4.66T6.76B69,045%
FUNDAMENTALS RATINGS
TAK vs ZTS: Fundamental Ratings
TAK
ZTS
OUTLOOK RATING
1..100
5574
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10078
SMR RATING
1..100
8419
PRICE GROWTH RATING
1..100
5460
P/E GROWTH RATING
1..100
2175
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (8) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZTS (65) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew somewhat faster than ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (78) in the Pharmaceuticals Generic industry is in the same range as TAK (100) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew similarly to TAK’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TAK (84) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew somewhat faster than TAK’s over the last 12 months.

TAK's Price Growth Rating (54) in the Pharmaceuticals Major industry is in the same range as ZTS (60) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to ZTS’s over the last 12 months.

TAK's P/E Growth Rating (21) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZTS (75) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TAKZTS
RSI
ODDS (%)
Bearish Trend 1 day ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
63%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
57%
MACD
ODDS (%)
Bearish Trend 1 day ago
41%
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
58%
Advances
ODDS (%)
Bullish Trend 12 days ago
43%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 16 days ago
55%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
38%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BOXX112.800.03
+0.03%
Alpha Architect 1-3 Month Box ETF
SPBW26.09-0.02
-0.08%
AllianzIM Buffer20 Allocation ETF
WBIG22.32-0.08
-0.36%
WBI BullBear Yield 3000 ETF
OCCI6.27-0.03
-0.48%
OFS Credit Company
XSVM53.78-0.64
-1.18%
Invesco S&P SmallCap Value with Momt ETF

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-2.42%
ELAN - ZTS
48%
Loosely correlated
-0.93%
VTRS - ZTS
44%
Loosely correlated
-1.41%
PAHC - ZTS
42%
Loosely correlated
-1.09%
AMRX - ZTS
39%
Loosely correlated
-0.72%
PBH - ZTS
36%
Loosely correlated
-1.34%
More